⌕
Eton Pharmaceuticals · ETON · Nasdaq
Tenet 47 · Mixed
Compare
$63.88−0.08%At closeTenet 47 · Mixed
$63.88−0.05 (−0.08%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Eton Pharmaceuticals (ETON) Institutional Ownership

13F filers reported holding 69.9% of Eton Pharmaceuticals (ETON) shares as of Jun 30, 2026, across 164 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

4 figures withheld by our checks. Each blank figure names its reason.

Held by 13F filers
69.9%
Jun 30, 2026
13F filers
164
quarter ended Jun 30, 2026
13F value
$730.2M
20.2M shares

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 164 13F filers for Jun 30, 2026, over shares outstanding implied from the current quote, measured 140 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 10, 2026CASAMENTO CHARLES JdirectorAcquired · Option exercise12,500$7.31↗
Nov 10, 2026CASAMENTO CHARLES JdirectorAcquired · Option exercise27,400$3.58↗
Nov 10, 2026CASAMENTO CHARLES JdirectorAcquired · Option exercise19,655$8.61↗
Nov 10, 2026CASAMENTO CHARLES JdirectorAcquired · Option exercise21,000$3.78↗
Nov 10, 2026CASAMENTO CHARLES JdirectorDisposed · Open-market sale6,380$64.33↗
Nov 10, 2026CASAMENTO CHARLES JdirectorDisposed · Open-market sale14,715$65.32↗
Nov 10, 2026CASAMENTO CHARLES JdirectorDisposed · Open-market sale22,601$66.26↗
Nov 10, 2026CASAMENTO CHARLES JdirectorDisposed · Open-market sale33,956$67.11↗
Nov 10, 2026CASAMENTO CHARLES JdirectorDisposed · Open-market sale2,903$67.87↗
Nov 10, 2026CASAMENTO CHARLES JdirectorDisposed · Option exercise12,500Stock Option—↗
Nov 10, 2026CASAMENTO CHARLES JdirectorDisposed · Option exercise27,400Stock Option—↗
Nov 10, 2026CASAMENTO CHARLES JdirectorDisposed · Option exercise19,655Stock Option—↗
Nov 10, 2026CASAMENTO CHARLES JdirectorDisposed · Option exercise21,000Stock Option—↗
Oct 6, 2026Krempa DavidChief Business OfficerDisposed · Open-market sale4,166$55.07↗
Oct 2, 2026Krempa DavidChief Business OfficerAcquired · Option exercise10,522—↗
Oct 2, 2026Krempa DavidChief Business OfficerDisposed · Option exercise10,522Restricted Stock Units—↗
Aug 28, 2026MAIER PAUL VdirectorAcquired · Option exercise50,000$3.78↗
Aug 28, 2026MAIER PAUL VdirectorDisposed · Open-market sale36,387$58.64↗
Aug 28, 2026MAIER PAUL VdirectorDisposed · Open-market sale13,485$60.21↗
Aug 28, 2026MAIER PAUL VdirectorDisposed · Open-market sale128$61.77↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Eton Pharmaceuticals do institutions hold?

13F filers reported holding 69.9% of Eton Pharmaceuticals' shares as of Jun 30, 2026, across 164 filers.

How many 13F filers hold Eton Pharmaceuticals?

Eton Pharmaceuticals was held by 164 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.